/Abbvie%20Inc%20logo%20and%20meds-%20by%20Ascannio%20via%20Shutterstock.jpg)
AbbVie Inc. (ABBV), headquartered in North Chicago, Illinois, is a biopharmaceutical company discovers, develops, manufactures, and sells pharmaceuticals worldwide. Valued at $346.8 billion by market cap, the company discovers and develops medicines and therapies that solve health issues across immunology, oncology, aesthetics, neuroscience, and eye care.
Shares of this drug giant have outperformed the broader market over the past year. ABBV has gained 15% over this time frame, while the broader S&P 500 Index ($SPX) has rallied nearly 8.2%. In 2025, ABBV stock is up 5.3%, surpassing the SPX’s 4.7% decline on a YTD basis.